Variable | May/June 2020 | December 2020 | Longitudinal sample | ||||
---|---|---|---|---|---|---|---|
All (N = 1477) | Seropositive (N = 18) | Seronegative (N = 1459) | All (N = 1223) | Seropositive (N = 56) | Seronegative (N = 1167) | All (N = 756) | |
Age in years, median (IQR) | 41 (32–51) | 37 (27.8–49.3) | 41 (32–51) | 40 (32–51) | 40 (30–47) | 40 (32–51) | 43 (34–52) |
Age groups in years | Â | Â | Â | Â | Â | Â | Â |
 16–29 | 189 (12.8%) | 5 (27.8%) | 184 (12.6%) | 176 (14.4%) | 12 (21.4%) | 164 (14.0%) | 66 (8.7%) |
 30–39 | 503 (34.1%) | 4 (22.2%) | 499 (34.2%) | 405 (33.1%) | 15 (26.8%) | 390 (33.4%) | 246 (32.5%) |
 40–49 | 349 (23.6%) | 5 (27.8%) | 344 (23.6%) | 284 (23.2%) | 20 (35.7%) | 264 (22.6%) | 195 (25.8%) |
 50–59 | 358 (24.2%) | 3 (16.7%) | 355 (24.3%) | 281 (23.0%) | 6 (10.7%) | 275 (23.5%) | 211 (27.9%) |
 60+ | 73 (4.9%) | 1 (5.6%) | 72 (4.9%) | 58 (4.7%) | 2 (3.6%) | 56 (4.8%) | 38 (5.0%) |
 Unknown | 5 (0.3%) | 0 | 5 (3.4%) | 19 (1.6%) | 1 (1.8%) | 19 (1.6%) | 0 (0.0%) |
Gender | Â | Â | Â | Â | Â | Â | Â |
 Female | 1038 (70.3%) | 12 (66.7%) | 1026 (70.3%) | 842 (68.8%) | 31 (55.4%) | 811 (69.5%) | 527 (69.7%) |
 Male | 436 (29.5%) | 6 (33.3%) | 430 (29.5%) | 380 (31.1%) | 24 (42.9%) | 356 (30.5%) | 229 (30.3%) |
 Diverse | 1 (0.1%) | 0 | 1 (0.1%) | 1 (0.1%) | 1 (1.8%) | 0 | 0 (0.0%) |
 Unknown | 2 (0.1%) | 0 | 2 (0.1%) | 0 (0.0%) | 0 | 0 | 0 (0.0%) |
Self-reported COVID-19-like symptomsa | Â | Â | Â | Â | Â | Â | Â |
 Yes | 140 (9.5%) | 7 (38.9%) | 133 (9.1%) | 193 (15.8%) | 21 (37.5%) | 172 (14.7%) | 115 (15.2%) |
 No | 1148 (77.8%) | 10 (55.6%) | 1138 (78.0%) | 1013 (82.8%) | 34 (60.7%) | 979 (83.9%) | 627 (82.9%) |
 Unknown | 189 (12.8%) | 1 (5.6%) | 188 (12.9%) | 17 (1.4%) | 1 (1.8%) | 16 (13.7%) | 14 (1.9%) |
Type of profession | Â | Â | Â | Â | Â | Â | Â |
 Nurse | 469 (31.8%) | 6 (33.3%) | 463 (31.7%) | 326 (26.7%) | 22 (39.3%) | 305 (26.1%) | 189 (25.0%) |
 Physician | 307 (20.8%) | 8 (44.4%) | 299 (20.5%) | 264 (21.6%) | 14 (25.0%) | 250 (21.4%) | 167 (22.1%) |
 Other allied health professionals | 298 (20.2%) | 2 (11.1%) | 296 (20.3%) | 276 (22.6%) | 10 (17.9%) | 266 (22.8%) | 178 (23.5%) |
 Administration/other facility management | 367 (24.8%) | 1 (5.6%) | 366 (25.1%) | 325 (26.6%) | 9 (16.1%) | 316 (27.1%) | 211 (27.9%) |
 Unknown | 37 (2.5%) | 1 (5.6%) | 35 (2.4%) | 31 (2.5%) | 1 (1.8%) | 30 (2.6%) | 11 (1.5%) |
SARS-CoV-2 occupational risk | Â | Â | Â | Â | Â | Â | Â |
 High | 74 (5.0%) | 3 (16.7%) | 71 (4.9%) | 58 (4.7%) | 13 (23.2%) | 45 (3.9%) | 37 (4.9%) |
 Moderate | 204 (13.8%) | 8 (44.4%) | 196 (13.4%) | 200 (16.4%) | 12 (21.4%) | 188 (16.1%) | 99 (13.1%) |
 Low | 843 (57.1%) | 7 (38.9%) | 836 (57.3%) | 619 (50.6%) | 26 (46.4%) | 593 (50.8%) | 394 (52.1%) |
 Very low | 337 (22.8%) | 0 | 337 (23.1%) | 332 (27.1%) | 5 (8.9%) | 327 (28.0%) | 218 (28.8%) |
Unknown | 19 (1.3%) | 0 | 19 (1.3%) | 14 (1.1%) | 0 | 14 (1.2%) | 8 (1.1%) |